Stock Options and Restricted Stock - Summary of Activity for Restricted Stock Programs (Detail) - $ / shares		3 Months Ended				6 Months Ended			12 Months Ended
		Jun. 30, 2024		Mar. 31, 2024		Jun. 30, 2024		Jun. 30, 2023	Dec. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares, vested						(234,330)
Grant price per share, cancelled, lower limit	[1]			$ 4.89
Grant price per share, cancelled, upper limit	[1]			$ 7.25
Restricted Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares, beginning balance		889,361	[2]	995,376		995,376		857,288	857,288
Number of shares, granted		0		296,178		296,178		316,483	399,793
Number of shares, cancelled		(1,696)		(1,208)					(12,807)
Number of shares, vested		0		(400,985)	[3]				(248,898)	[3]
Number of shares, ending balance		887,665	[2]	889,361	[2]	887,665	[2]		995,376
Grant price per share, lower range limit beginning balance		$ 4.89	[2]	$ 4.89		$ 4.89		$ 4.89	$ 4.89
Grant price per share, upper range limit beginning balance		9.37	[2]	9.37		9.37		7.25	7.25
Grant price per share, granted, lower limit									7.67
Grant price per share, granted, upper limit		0		8.97					9.37
Grant price per share, cancelled, lower limit		4.89		6.86					4.89
Grant price per share, cancelled, upper limit		9.37		9.37					8.4
Grant price per share, vested, lower limit	[3]			4.89					4.89
Grant price per share, vested, upper limit		0		8.4	[3]				7.68	[3]
Grant price per share, lower range limit ending balance		4.89	[2]	4.89	[2]	4.89	[2]		4.89
Grant price per share, upper range limit ending balance		9.37	[2]	9.37	[2]	9.37	[2]		9.37
Weighted average grant price beginning balance		8.18	[2]	7.74		7.74		$ 7.27	7.27
Weighted average grant price, granted		0		8.97					8.34
Weighted average grant price, cancelled		7.88		8.13					7.24
Weighted average grant price, vested		0		7.69	[3]				7.1	[3]
Weighted average grant price, ending balance		$ 8.18	[2]	$ 8.18	[2]	$ 8.18	[2]		$ 7.74

[1] The intrinsic value of the options vested was $0.4 million for the three and six months ended June 30, 2024

[2] The aggregate fair value of the restricted stock was $6.8 million as of June 30, 2024. The remaining vesting period was 2.7 years at June 30, 2024.

[3] The aggregate fair value of the restricted stock vested was $2.7 million for the six months ended June 30, 2024 and $2.1 million for the year ended December 31, 2023